Nu-Med Plus Inc (NUMD)
OTHER OTC:NUMD
US Market
Holding NUMD?
Track your performance easily

Nu-Med Plus (NUMD) Financial Statements

2 Followers

Nu-Med Plus Financial Overview

Nu-Med Plus's market cap is currently ―. The company's EPS TTM is $-0.001; its P/E ratio is -17.14; Nu-Med Plus is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue--$ -3.00K-$ 3.00K
Gross Profit--$ -3.00K-$ 3.00K
EBIT$ -17.29K$ 20.28K$ -55.34K$ -23.07K$ 20.37K
EBITDA$ -17.29K$ 20.28K$ -55.34K-$ 20.37K
Net Income Common Stockholders$ -17.29K$ -21.83K$ -56.60K$ -24.32K$ 19.14K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 6.36K$ 6.81K$ 29.96K$ 53.03K
Total Assets$ 11.04K$ 9.02K$ 13.46K$ 36.55K$ 59.07K
Total Debt$ 100.00K$ 100.00K$ 100.00K$ 100.00K$ 100.00K
Net Debt$ 100.00K$ 93.64K$ 93.19K$ 70.04K$ 46.97K
Total Liabilities$ 196.91K$ 177.59K$ 160.21K$ 152.10K$ 150.30K
Stockholders Equity$ -185.86K$ -168.58K$ -146.75K$ -115.55K$ -91.23K
Cash Flow-
Free Cash Flow$ -2.31K$ -450.00$ -4.28K-$ -20.17K
Operating Cash Flow$ -2.31K$ -450.00$ -4.28K-$ -20.17K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Nu-Med Plus Earnings and Revenue History

Nu-Med Plus Debt to Assets

Nu-Med Plus Cash Flow

Nu-Med Plus Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis